Literature DB >> 2890716

Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalised convulsion.

A Pitkänen1, J Jolkkonen, P Riekkinen.   

Abstract

The possible role of different peptidergic systems in the postictal stage of human epilepsy was studied by measuring beta-endorphin, somatostatin, and prolactin levels by radioimmunoassay of cerebrospinal fluid (CSF) from nine epileptic patients. The first sample was taken within 2 hours after generalised tonic-clonic convulsion, and the second sample was obtained interictally after 1-4 days without any kind of clinically observable seizures. beta-endorphin was elevated postictally (p = 0.044) compared with interictal levels. SLI and PROL were similar in both samples. The present study suggests that in humans beta-endorphin is released into CSF during generalised seizures. This may indicate that neurons containing beta-endorphin are activated during a seizure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890716      PMCID: PMC1032453          DOI: 10.1136/jnnp.50.10.1294

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala.

Authors:  M Rezek; V Havlicek; K R Hughes; H Friesen
Journal:  Neuropharmacology       Date:  1977-03       Impact factor: 5.250

2.  Profound suppression of kindled seizures by cysteamine: possible role of somatostatin to kindled seizures.

Authors:  T Higuchi; G S Sikand; N Kato; J A Wada; H G Friesen
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

3.  Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling.

Authors:  M J Iadarola; C Shin; J O McNamara; H Y Yang
Journal:  Brain Res       Date:  1986-02-12       Impact factor: 3.252

4.  Neuropathological findings in primary generalized epilepsy: a study of eight cases.

Authors:  H J Meencke; D Janz
Journal:  Epilepsia       Date:  1984-02       Impact factor: 5.864

5.  Effect of somatostatin (SRIF) and L-glutamate on neurons of the sensorimotor cortex in awake habituated rabbits.

Authors:  S Ioffe; V Havlicek; H Friesen; V Chernick
Journal:  Brain Res       Date:  1978-09-22       Impact factor: 3.252

6.  Variations of prolactin content in human cerebrospinal fluid after metoclopramide and morphine.

Authors:  E Rolandi; C Perria; R Franceschini; C Siani; V Messina; N Francaviglia; T Barreca
Journal:  Life Sci       Date:  1985-03-04       Impact factor: 5.037

7.  Effect of pentylenetetrazol-induced convulsions on somatostatin-like immunoreactivity in rat cerebrospinal fluid.

Authors:  A Pitkänen; J Jolkkonen; K L Honkanen; P Riekkinen
Journal:  Neuropeptides       Date:  1987-01       Impact factor: 3.286

8.  Changes of immunoreactive somatostatin and beta-endorphin content in rat brain after amygdaloid kindling.

Authors:  N Kato; T Higuchi; H G Friesen; J A Wada
Journal:  Life Sci       Date:  1983-05-23       Impact factor: 5.037

9.  beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease.

Authors:  J T Jolkkonen; H S Soininen; P J Riekkinen
Journal:  J Neurol Sci       Date:  1987-02       Impact factor: 3.181

10.  Prolactin changes after seizures classified by EEG monitoring.

Authors:  K D Laxer; J P Mullooly; B Howell
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  3 in total

1.  Somatostatin in cerebrospinal fluid after generalised convulsions or cerebral infarction in humans.

Authors:  H Cramer; K M Heitzelmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

Review 2.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

Review 3.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.